In Brief: FDA FY 1999 goals
This article was originally published in The Tan Sheet
Executive Summary
FDA FY 1999 goals: Public reports from the Special Nutritionals Adverse Events Monitoring System will at least double in 1999 from the current two per year, FDA says in its FY 1999 budget justification. The agency notes it will "continue to respond to safety concerns associated with the rapidly expanding use and misuse of dietary supplement products such as ephedra." Regarding OTCs, FDA expresses its commitment to improving "the legibility and clarity of OTC drug labels" and "the consumer's ability to read and understand important warnings and usage directions." The President's budget request for FDA was issued Feb. 2 ("The Tan Sheet" Feb. 9, p. 15)...